Pathophysiology of cerebral ischemia.

The purpose of this manuscript is to briefly review the pathophysiology of cerebral ischemia. Ischemic thresholds are well-defined in lower animals. The concept of the ischemic penumbra may include regions of brain around deeper regions of ischemia but has also been defined in terms of brain salvageable by reperfusion or by pharmacological therapies. The principal pathophysiological processes in cerebral ischemia are energy failure, loss of cell ion homeostasis, acidosis, increased intracellular calcium, excitotoxicity, and free radical-mediated toxicity. The underlying biochemical processes are similar regardless of the amount of brain that is made ischemic or the duration of ischemia. The relative contributions of each process are believed to vary significantly especially in relation to the level of cerebral blood flow. Neurons may die by necrosis or apoptosis. In the core of an infarct where blood flow is very low, the predominant process is energy failure and rapid necrotic cell death. Reperfusion of ischemic tissue produces an influx of inflammatory cells and of oxygen that can cause increases in oxygen-derived free radicals. Free radicals are also important in prolonged ischemia. There is interest in changes in gene expression after ischemia. Induction of heat shock proteins suggests that gene expression changes may protect neurons from death. Changes in gene expression also may initiate apoptosis or other detrimental processes. Although advances have been made, there are still no proven pharmacological therapies to rescue ischemic human neurons. Such therapies do appear to be on the horizon.

[1]  A. Villringer,et al.  [Pathophysiology of cerebral ischemia]. , 1999, Zeitschrift fur arztliche Fortbildung und Qualitatssicherung.

[2]  C. Epstein,et al.  Reduction of CuZn-Superoxide Dismutase Activity Exacerbates Neuronal Cell Injury and Edema Formation after Transient Focal Cerebral Ischemia , 1997, The Journal of Neuroscience.

[3]  G. Schmid-Schönbein,et al.  Experimental Antileukocyte Interventions in Cerebral Ischemia , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  M. Moskowitz,et al.  Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice are Attenuated by Nitro-L-Arginine , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[5]  P. Akins,et al.  Immediate early gene expression in response to cerebral ischemia. Friend or foe? , 1996, Stroke.

[6]  P. Chan,et al.  Role of oxidants in ischemic brain damage. , 1996, Stroke.

[7]  Charles Tator,et al.  Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. , 1996, Neurosurgery.

[8]  Kuniaki Saito,et al.  Early increases in TNF-α, IL-6 and IL-1β levels following transient cerebral ischemia in gerbil brain , 1996, Neuroscience Letters.

[9]  Y. Ben-Ari,et al.  Apoptosis and Necrosis after Reversible Focal Ischemia: An in Situ DNA Fragmentation Analysis , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  K. Kogure,et al.  Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain , 1996, Brain Research.

[11]  Joakim Bjorkdahl Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? , 1996 .

[12]  F. Sharp,et al.  The stress gene response in brain. , 1996, Cerebrovascular and brain metabolism reviews.

[13]  A. Basile,et al.  Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. , 1996, Neuroscience letters.

[14]  W. Liles,et al.  Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. , 1995, The Journal of infectious diseases.

[15]  S. Finklestein,et al.  Delayed Treatment with Intravenous Basic Fibroblast Growth Factor Reduces Infarct Size following Permanent Focal Cerebral Ischemia in Rats , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[17]  D. Choi,et al.  Potentiated necrosis of cultured cortical neurons by neurotrophins. , 1995, Science.

[18]  L. Benítez-Bribiesca [Apoptosis in the pathogenesis and treatment of disease]. , 1995, Gaceta medica de Mexico.

[19]  D. Graham,et al.  Therapeutic Potential of Endothelin Receptor Antagonists in Experimental Stroke , 1995, Journal of cardiovascular pharmacology.

[20]  J. D. Elliott,et al.  The Endothelin Receptor Antagonist SB 217242 Reduces Cerebral Focal Ischemic Brain Injury , 1995, Journal of cardiovascular pharmacology.

[21]  Jean-Claude Martinou,et al.  Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia , 1994, Neuron.

[22]  M. Moskowitz,et al.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. , 1994, Science.

[23]  Wei Zhao,et al.  Increased Expression of ICAM‐1 During Reoxygenation in Brain Endothelial Cells , 1994, Stroke.

[24]  T. Neumann-Haefelin,et al.  Differential Expression of the Immediate Early Genes c-Fos, c-Jun, JunB, and NGFI-B in the Rat Brain following Transient Forebrain Ischemia , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  F. Barone,et al.  Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. , 1994, Cerebrovascular and brain metabolism reviews.

[26]  C. Epstein,et al.  Brain infarction is not reduced in SOD-1 transgenic mice after a permanent focal cerebral ischemia. , 1993, Neuroreport.

[27]  A. Aguzzi,et al.  Differential Transcription and Translation of Immediate Early Genes in the Gerbil Hippocampus after Transient Global Ischemia , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  E. Golanov,et al.  Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions , 1993, Nature.

[29]  B. Siesjö Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. , 1992, Journal of neurosurgery.

[30]  C. Epstein,et al.  Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Dubinsky,et al.  Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  W. Pulsinelli,et al.  The Effect of Nimodipine Pretreatment on Focal Cerebral Ischemia in the Hypertensive Rat , 1991 .

[33]  A. Buchan Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted? , 1990, Cerebrovascular and brain metabolism reviews.

[34]  J. Grotta,et al.  Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. , 1989, Stroke.

[35]  R. Busto,et al.  Effect of Ischemia on the In Vivo Release of Striatal Dopamine, Glutamate, and γ‐Aminobutyric Acid Studied by Intracerebral Microdialysis , 1988, Journal of neurochemistry.

[36]  P. Kochanek,et al.  Effects of prostacyclin, indomethacin, and heparin on cerebral blood flow and platelet adhesion after multifocal ischemia of canine brain. , 1988, Stroke.

[37]  P. Lyden,et al.  Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. , 1988, Archives of neurology.

[38]  D. Choi,et al.  Glutamate neurotoxicity in cortical cell culture is calcium dependent , 1985, Neuroscience Letters.

[39]  W. Schlaepfer,et al.  Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments. , 1985, Progress in brain research.

[40]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[41]  Takaaki Kirino,et al.  Delayed neuronal death in the gerbil hippocampus following ischemia , 1982, Brain Research.

[42]  Fred Plum,et al.  Temporal profile of neuronal damage in a model of transient forebrain ischemia , 1982, Annals of neurology.

[43]  J Astrup,et al.  Oxygen and glucose consumption related to Na+-K+ transport in canine brain. , 1981, Stroke.

[44]  R. Ojemann,et al.  Thresholds of focal cerebral ischemia in awake monkeys. , 1981, Journal of neurosurgery.

[45]  D. T. Hope,et al.  Barbiturates in Focal Ischemia of Primate Cortex: Effects on Blood Flow Distribution, Evoked Potential and Extracellular Potassium , 1979, Stroke.

[46]  J. de Cree,et al.  The Rheological Effects of Cinnarizine and Flunarizine in Normal and Pathologic Conditions , 1979, Angiology.

[47]  L. Symon,et al.  Ischemic Brain Edema Following Middle Cerebral Artery Occlusion in Baboons: Relationship Between Regional Cerebral Water Content and Blood Flow at 1 to 2 Hours , 1979, Stroke.

[48]  T. Sundt,et al.  Microcirculatory obstruction in focal cerebral ischemia. Relationship to neuronal alterations. , 1975, Mayo Clinic proceedings.

[49]  Y. Olsson,et al.  Impaired microvascular filling after focal cerebral ischemia in monkeys. , 1972, Journal of neurosurgery.

[50]  M. Kowada,et al.  Cerebral ischemia. II. The no-reflow phenomenon. , 1968, The American journal of pathology.